PDE4A and asthma: No PDE inhibitor has yet reached the market as a therapeutic option for asthma. The current focus is on the development of PDE inhibitors that interact simultaneously with different PDE types. CHF6001 and RPL554 are the PDE4 inhibitors under development for asthma to date